Skip to main content
NC002 Phase II Trial to Evaluate the Efficacy, Safety and Tolerability of the Following: PA-824 Plus Moxifloxacin Plus Pyrazinamide in Drug Sensitive and Multi-Drug Resistant Patients
3 / 2012
Pretomanid (PA-824) in combination with bedaquiline, moxifloxacin, pyrazinamide, and linezolid
©2016 Working Group on New TB Drugs. All Rights Reserved.
Terms of Reference
Site by Darby Communications